Cara Therapeutics | CARA - Trade Debtors

Stock Price
4.18
Daily Change
-0.03 -0.71%
Monthly
41.22%
Yearly
-83.68%
Q2 Forecast
3.07

Cara Therapeutics reported $2.24M in Trade Debtors for its fiscal quarter ending in March of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Assertio Holdings USD 39.91M 2.7M Jun/2024
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cassava Sciences USD 120K 697K Dec/2025
Chugai Pharma JPY 352.94B 90.17B Mar/2026
Cipla INR 74.61B 19.39B Sep/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.38M 448K Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Pacira USD 125.64M 1.57M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
RedHill Biopharma USD 5.35M 1.78M Jun/2025
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024